Opportunity Information: Apply for RFA CA 21 038

The Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers funding opportunity (RFA-CA-21-038) is an NIH cooperative agreement (U54) designed to build a coordinated, networked research infrastructure focused on precision cancer prevention and cancer interception. The central purpose is not to run clinical trials, but to organize and support collaborative, multi-team efforts that discover and advance molecularly targeted or immunologically targeted agents intended to stop, delay, or derail cancer development in people who are at elevated risk. In practical terms, the program is aimed at identifying and developing preventive or early-intervention agents that can act on specific biological mechanisms involved in early carcinogenesis, rather than relying only on broad, non-specific prevention approaches.

A key emphasis of the opportunity is the creation of an agile and effective network of centers that can work together rather than operate as isolated projects. The FOA references a companion FOA, signaling that NIH is building a broader CAP-IT ecosystem where different awards play complementary roles. The expectation is that awardees will participate in a coordinated program structure typical of a cooperative agreement, where NIH has substantial involvement in scientific direction, coordination, and milestone-driven progress. The ultimate research theme is targeted agent discovery for prevention and interception, meaning the science should be oriented toward finding agents that can be rationally matched to high-risk states, early lesions, or biological pathways that precede invasive cancer, with an eye toward precision use in defined populations.

This is a discretionary federal funding opportunity under NIH, categorized within education and health, and associated with CFDA numbers 93.394 and 93.395. The instrument type is a cooperative agreement, which generally implies more active programmatic stewardship by NIH compared with standard grants. The opportunity was created on July 15, 2021, and the original closing date listed is October 7, 2021. The text provided does not specify an award ceiling or the expected number of awards, so applicants would normally need to consult the full FOA to understand budget limits, project period expectations, and the anticipated scale of the center awards.

Eligibility is broad and includes many common public and private organizational types. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; tribal organizations other than federally recognized governments; nonprofit organizations with or without 501(c)(3) status (when not operating as institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations as permitted by NIH. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal government agencies, Indian/Native American Tribal Governments other than federally recognized entities, and U.S. territories or possessions.

At the same time, there are clear restrictions related to foreign participation. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement, which typically means a U.S.-based applicant may include certain types of foreign collaborations or subcomponents if justified and compliant with NIH policy, even though a foreign institution cannot be the primary applicant.

Overall, CAP-IT Centers are meant to function as hubs for collaborative discovery and advancement of targeted prevention and interception agents, aligned to the biology of early cancer development and focused on high-risk populations. The “Clinical Trial Not Allowed” designation signals that the work supported under this specific U54 announcement should not include clinical trial activities as defined by NIH, keeping the scope centered on coordinated preclinical, translational, and discovery work needed to generate and prioritize candidate agents for precision prevention and interception within a networked national program.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394, 93.395.
  • This funding opportunity was created on 2021-07-15.
  • Applicants must submit their applications by 2021-10-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 21 038

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: OPE: Higher Education Emergency Relief Fund (HEERF), Section 2003 of the American Rescue Plan (ARP) for Institutions of Higher Education (IHE) that meet the criteria for the Minority Serving Institutions (MSIs) Program Assistance Listing Number 84.425L

Previous opportunity: NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 21 038

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 21 038) also looked into and applied for these:

Funding Opportunity
Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) Apply for PAR 21 287

Funding Number: PAR 21 287
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PAR 21 290

Funding Number: PAR 21 290
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 042

Funding Number: RFA CA 21 042
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) Apply for RFA CA 21 041

Funding Number: RFA CA 21 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 21 285

Funding Number: PAR 21 285
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Apply for RFA DA 22 033

Funding Number: RFA DA 22 033
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 21 294

Funding Number: PAR 21 294
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 21 286

Funding Number: PAR 21 286
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) Apply for RFA CA 21 050

Funding Number: RFA CA 21 050
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) Apply for RFA CA 21 051

Funding Number: RFA CA 21 051
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $375,000
Advancing Validated Drug Targets for Substance Use Disorders (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 22 018

Funding Number: RFA DA 22 018
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Validated Drug Targets for Substance Use Disorders (R43/R44 - Clinical Trial Not Allowed) Apply for RFA DA 22 023

Funding Number: RFA DA 22 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 049

Funding Number: RFA CA 21 049
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,200,000
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed) Apply for RFA CA 21 048

Funding Number: RFA CA 21 048
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,500,000
Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional) Apply for PAR 21 310

Funding Number: PAR 21 310
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required) Apply for PAR 21 309

Funding Number: PAR 21 309
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed) Apply for RFA CA 21 053

Funding Number: RFA CA 21 053
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed) Apply for RFA CA 21 052

Funding Number: RFA CA 21 052
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional) Apply for RFA DA 22 022

Funding Number: RFA DA 22 022
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 21 277

Funding Number: PAR 21 277
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 21 038", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: